XML 26 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - KRG Trust - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income (loss) $ 4,416 $ 48,383 $ (12,154)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 397,985 429,970 472,969
Loss (gain) on sales of operating properties, net 864 (22,601) (27,069)
Gain on sale of unconsolidated property, net (2,325) 0 0
Impairment charges 66,201 477 0
Loss on extinguishment of debt 180 0 0
Straight-line rent (12,089) (11,812) (16,632)
Compensation expense for equity awards 10,740 10,116 10,280
Amortization of debt fair value adjustments (12,038) (13,366) (13,521)
Amortization of in-place lease assets and liabilities (10,078) (12,025) (4,821)
Changes in assets and liabilities:      
Tenant receivables (2,610) (940) (16,763)
Deferred costs and other assets (23,647) (29,912) 7,522
Accounts payable, accrued expenses, deferred revenue and other liabilities 1,429 (3,642) (20,528)
Net cash provided by operating activities 419,028 394,648 379,283
Cash flows from investing activities:      
Acquisitions of interests in properties (40,561) (78,274) (100,142)
Capital expenditures (140,949) (142,578) (158,540)
Net proceeds from sales of land 13,198 3,166 4,716
Net proceeds from sales of operating properties 30,409 137,687 75,699
Investment in short-term deposits (615,000) 0 0
Proceeds from short-term deposits 265,000 0 125,000
Small business loan repayments 0 346 657
Change in construction payables 479 (2,078) 6,341
Distribution from unconsolidated joint venture 1,618 0 1,245
Capital contributions to unconsolidated joint ventures (13,185) 0 (125)
Net cash used in investing activities (498,991) (81,731) (45,149)
Cash flows from financing activities:      
Proceeds from issuance of common shares, net 74 86 30
Repurchases of common shares upon the vesting of restricted shares (907) (767) (1,535)
Debt and equity issuance costs (18,992) (767) (5,159)
Loan proceeds 732,993 369,095 455,000
Loan payments (314,756) (544,410) (568,963)
Distributions paid – common shareholders (221,793) (210,546) (179,624)
Distributions paid – redeemable noncontrolling interests (3,717) (2,952) (2,622)
Distributions to noncontrolling interests (817) (3,196) 0
Acquisition of partner’s noncontrolling interest in Killingly Commons joint venture 0 0 (9,654)
Net cash provided by (used in) financing activities 172,085 (393,457) (312,527)
Net change in cash, cash equivalents and restricted cash 92,122 (80,540) 21,607
Cash, cash equivalents and restricted cash, beginning of year 41,430 121,970 100,363
Cash, cash equivalents and restricted cash, end of year 133,552 41,430 121,970
Supplemental disclosures      
Cash paid for interest, net of capitalized interest 130,630 120,870 113,744
Non-cash investing and financing activities      
Exchange of redeemable noncontrolling interests for common shares $ 0 $ 1,568 $ 1,670